Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
Department of Anaesthesiology and Intensive Care Medicine AUVA Trauma Centre Salzburg, Academic Teaching Hospital of the Paracelsus Medical University, Dr.-Franz-Rehrl-Platz 5, 5010, Salzburg, Austria.
Scand J Trauma Resusc Emerg Med. 2021 Nov 18;29(1):161. doi: 10.1186/s13049-021-00978-z.
As pediatric patients are typically rare among helicopter emergency medical systems (HEMS), children might be at risk for oligo-analgesia due to the rescuer's lack of experience and the fear of side effects.
In this retrospective analysis, data was obtained from the ÖAMTC HEMS digital database including 14 physician staffed helicopter bases in Austria over a 12-year timeframe. Primary missions involving pediatric trauma patients (< 15 years) not mechanically ventilated on-site were included. Analgesia was assessed and compared between the age groups 0-5, 6-10 and 11-14 years.
Of all flight missions, 8.2% were dedicated to children < 15 years. Analgetic drugs were administered in 31.4% of all primary missions (3874 of 12,324), wherefrom 2885 were injured and non-ventilated (0-5 yrs.: n = 443; 6-10 yrs.: n = 902; 11-14 yrs.: n = 1540). The majority of these patients (> 75%) suffered moderate to severe pain, justifying immediate analgesia. HEMS physicians typically chose a monotherapy with an opioid (n = 1277; 44.3%) or Esketamine (n = 1187; 41.1%) followed by the combination of both (n = 324; 11.2%). Opioid use increased (37.2% to 63.4%) and Esketamine use decreased (66.1% to 48.3%) in children < 6 vs. > 10 years. Esketamine was more often administered in extremity (57.3%) than in head (41.5%) or spine injuries (32.3%). An intravenous access was less often established in children < 6 years (74.3% vs. 90.8%; p < 0.001). Despite the use of potent analgesics, 396 missions (13.7%) were performed without technical monitoring. Particularly regarding patient data at handover in hospital, merely < 10% of all missions featured complete documentation. Therefore, sufficient evaluation of the efficacy of pain relief was not possible. Yet, by means of respiratory measures required during transport, severe side effects such as respiratory insufficiency, were barely noted.
In the physician-staffed HEMS setting, pediatric trauma patients liberally receive opioids and Esketamine for analgesia. With regard to severe respiratory insufficiency during transport, the application of these potent analgesics seems safe.
由于儿科患者在直升机紧急医疗服务(HEMS)中通常较为罕见,因此救援人员可能因经验不足和担心副作用而导致儿童接受的镇痛药物不足。
在这项回顾性分析中,从奥地利的 14 个配备医生的直升机基地的 ÖAMTC HEMS 数字数据库中获取了数据,时间跨度为 12 年。纳入了未在现场机械通气的儿科创伤患者(<15 岁)的主要任务。评估并比较了 0-5 岁、6-10 岁和 11-14 岁年龄组之间的镇痛情况。
在所有飞行任务中,8.2%专门用于<15 岁的儿童。在所有主要任务中(12324 次中的 3874 次),给予了镇痛药物,其中 2885 次为受伤且未通气的患者(0-5 岁:n=443;6-10 岁:n=902;11-14 岁:n=1540)。这些患者中,超过 75%的患者存在中重度疼痛,需要立即进行镇痛。HEMS 医生通常选择单一疗法,即使用阿片类药物(n=1277;44.3%)或 Esketamine(n=1187;41.1%),其次是两者联合使用(n=324;11.2%)。<6 岁儿童的阿片类药物使用率(37.2%至 63.4%)增加,Esketamine 使用率(66.1%至 48.3%)下降。Esketamine 更多地用于四肢(57.3%)损伤,而不是头部(41.5%)或脊柱损伤(32.3%)。<6 岁儿童建立静脉通路的比例较低(74.3%比 90.8%;p<0.001)。尽管使用了强效的镇痛药物,但仍有 396 次任务(13.7%)在没有技术监测的情况下进行。特别是在医院交接时的患者数据方面,仅有<10%的任务具有完整的记录。因此,无法对疼痛缓解的效果进行充分评估。然而,通过运输过程中需要的呼吸措施,可以发现,严重的副作用,如呼吸功能不全,几乎没有发生。
在配备医生的 HEMS 环境中,儿科创伤患者接受阿片类药物和 Esketamine 进行镇痛治疗。就运输过程中严重的呼吸功能不全而言,这些强效镇痛药物的应用似乎是安全的。